Awareness, Willingness to Accept and Factors Influencing Covid-19 Vaccination Amongst Antenatal Attendees at a Nigerian Tertiary Hospital
DOI:
https://doi.org/10.14738/jbemi.96.13591Keywords:
COVID-19 vaccine, pregnancy, awareness, uptake, side effectAbstract
COVID-19 infection can become severe in pregnancy. When fear enshrouds antenatal use of the vaccine, pregnant women and their unborn babies become at risk and at the same time act as the disease’s reservoirs. This study is aimed at determining the awareness, willingness to accept COVID- 19 vaccination among antenatal attendees as well as factors influencing COVID-19 vaccination at the Niger-Delta University Teaching Hospital, Okolobiri. The study was a descriptive cross sectional study. Three hundred and fifty pregnant women were interviewed after informed consent. The data acquired included the awareness and source of information on COVID-19 vaccine, its acceptance, reasons for vaccine hesitancy and side effects. Three hundred and thirty-eight pregnant women (96.6%) indicated awareness of the availability of the COVID-19 vaccine. Only 13 of the 350 pregnant women in this study had received the vaccine (3.7%). The television was the leading source of information about COVID-19 vaccines, (51.4%). The topmost reason for not been vaccinated was concern about the safety of the vaccines (39.2%). Age, religion, level of education and occupation were significantly associated with acceptance of COVID-19 vaccine. Eleven out of thirteen study subjects (84.6%) who have been vaccinated against COVID-19 had side effects. The commonest side effect of COVID-19 vaccination was malaise (84.6%). COVID-19 vaccine awareness in this study was optimal. However, its uptake in pregnancy was poor. Socio-demographic characteristics of antenatal attendees influences their use of COVID-19 vaccine. The COVID-19 vaccination side effects in pregnancy are mainly not life-threatening.
References
Morens DM, Breman JG, Calisher CH, Doherty PC, Hahn BH, Keusch GT, et al. The Origin of COVID-19 and Why It Matters. Am J Trop Med Hyg [Internet]. 2020 Sep 1 [cited 2021 Jul 20];103(3):955. Available from: /pmc/articles/PMC7470595/
JK T, JC K, DM M. The 1918 influenza pandemic: 100 years of questions answered and unanswered. Sci Transl Med [Internet]. 2019 Jul 24 [cited 2021 Jul 20];11(502). Available from:
Keni R, Alexander A, Nayak PG, Mudgal J, Nandakumar K. COVID-19: Emergence, Spread, Possible Treatments, and Global Burden. Front Public Heal. 2020 May 28;0:216.
Akande, Akande TM. COVID-19 pandemic: A global health burden. Niger Postgrad Med J [Internet]. 2020 Jul 1 [cited 2021 Jul 20];27(3):147. Available from: https://www.npmj.org/article.asp?issn=1117-1936;year=2020;volume=27;issue=3;spage=147;epage=155;aulast=Akande
Nigeria Centre for Disease Control [Internet]. [cited 2021 Jul 20]. Available from: https://ncdc.gov.ng/diseases/sitreps/?cat=14&name=An update of COVID-19 outbreak in Nigeria
Shaikh VS, Nazeruddin GM, Shaikh YI, Bloukh SH, Edis Z, Pathan HM. A recapitulation of virology, modes of dissemination, diagnosis, treatment, and preventive measures of COVID-19: A review. Eng Sci. 2020;10:11–23.
Lurie N, Sharfstein JM, Goodman JL. The Development of COVID-19 Vaccines: Safeguards Needed. JAMA [Internet]. 2020 Aug 4 [cited 2021 Aug 15];324(5):439–40. Available from: https://jamanetwork.com/journals/jama/fullarticle/2768156
COVID-19 Is a Perfect Storm for Vaccine Skepticism - The Atlantic [Internet]. [cited 2021 Aug 15]. Available from: https://www.theatlantic.com/science/archive/2020/05/covid-19-vaccine-skepticsconspiracies/611998/
Lambert PH, Ambrosino DM, Andersen SR, Baric RS, Black SB, Chen RT, et al. Consensus summary report for CEPI/BC March 12–13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines. Vaccine. 2020 Jun 26;38(31):4783–91.
Wang J, Peng Y, Xu H, Cui Z, Williams RO. The COVID-19 Vaccine Race: Challenges and Opportunities in Vaccine Formulation. AAPS PharmSciTech 2020 216 [Internet]. 2020 Aug 5 [cited 2021 Aug 15];21(6):1–12. Available from: https://link.springer.com/article/10.1208/s12249-020-01744-7
Vartak A, Sucheck SJ. Recent Advances in Subunit Vaccine Carriers. Vaccines 2016, Vol 4, Page 12 [Internet]. 2016 Apr 19 [cited 2021 Aug 15];4(2):12. Available from: https://www.mdpi.com/2076-393X/4/2/12/htm
Ayeotan O| ;, Egbeleke FA, Aletan OE, Fagbewesa AF, Olawuyi CO, Ayeotan O. Covid-19 Vaccine Benefits and Concerns: Nigerian Perspectives. J Clin Med Res [Internet]. 2021 [cited 2021 Aug 23];3(5):1–9. Available from: https://doi.org/10.37191/Mapsci-2582-4333-3
DY L, IV D, DV S, AI T, OV Z, AS D, et al. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. Lancet (London, England) [Internet]. 2021 Feb 20 [cited 2021 Aug 24];397(10275):671–81. Available from:
M V, SAC C, SA M, LY W, PM F, PK A, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet (London, England) [Internet]. 2021 Jan 9 [cited 2021 Aug 24];397(10269):99–111. Available from:
Seiyaboh EI, Baulch EK, Angaye TCN. Perspective of the residents on handwashing in reducing the spread of covid-19: A case study of Yenagoa metropolis, Bayelsa state, Nigeria.
Chibuzor Oriji P, Serena Tekenah E, Lukman O, Allagoa DO, Tekenah ES, Obagah L, et al. Predictors of acceptance of COVID-19 vaccine among patients at a tertiary hospital in South-South Nigeria. Int J Community Med Public Heal Allagoa DO al Int J Community Med Public Heal [Internet]. 2021 [cited 2021 Aug 24];8(5):2165–72. Available from: http://www.ijcmph.com 148
Liu H, Wang LL, Zhao SJ, Kwak-Kim J, Mor G, Liao AH. Why are pregnant women susceptible to COVID-19? An immunological viewpoint. J Reprod Immunol. 2020 Jun 1;139:103122.
Riley LE, Jamieson DJ. Inclusion of Pregnant and Lactating Persons in COVID-19 Vaccination Efforts. https://doi.org/107326/M21-0173 [Internet]. 2021 Jan 26 [cited 2021 Aug 24];174(5):701–2. Available from: https://www.acpjournals.org/doi/abs/10.7326/M21-0173
Anikwe CC, Ogah CO, Anikwe IH, Okorochukwu BC, Ikeoha CC. Coronavirus disease 2019: Knowledge, attitude, and practice of pregnant women in a tertiary hospital in Abakaliki, southeast Nigeria. Int J Gynecol Obstet [Internet]. 2020 Nov 1 [cited 2021 Aug 24];151(2):197–202. Available from: https://obgyn.onlinelibrary.wiley.com/doi/full/10.1002/ijgo.13293
COVID-19 Vaccine policies for regnant and lactating people worldwide. Covid-19 Maternal Immunization Tracker. Available at: https://www.comitglobal.org/country/ng. Accessed Sept 28, 2022.
JCVI. Joint Committee on Vaccination and Immunization: advice on priorty groups for COVID-19 Vaccination . Dec 30,2020.Availabe at: https://www.gov.uk/government/publications/priority-groups-for-coronavirus-covid-19-vacciantion-advice-from-the jcvi-30-decenber-2020/joint-committe-on-vaccination-and-immunizationadvice-priority-groups-for-covid-19-vaccination-30-december-2020
Yamini S, Tanvi S, Rakesh S. Vacciantion of pregnant women against COVID-19 in India and Indonesia: Moving beyond the option to opt out option. Int J Gynecol Obstet 2021, 155(3):549-550.
COVID-19 vaccination. Considerations for Obstetric-Gynecologic Care. Practice Advisory. ACOG December 2020. Updated Sept 20,2022. Available at: https://www.acog.org/clinical/clinical-guidance/practiceadvisory/article/2020/12/covid-19-vaccination-considerations-for-obstetric-gynecologic-care. Accessed 27 Sept 2022.
COVID-19. Pregnancy or Breastfeeding. Centres for Dieae Control and Prevention. Updated July 14, 2022. Available at: https:// www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/pregnancy.html. Accessed Sept, 27, 2022.
Shook LL, Ateyo CG, Yonker LM, et al. Durability of Anti-spike Antibodies in Infants After Maternal COVID-19 Vaccination or Natural Infection. JAMA. February 07 2022. Doi: https://doi.org/10.1001/jama.2022.1206.
Zauce LH, Wallace B, Smoots AN et al. Receipt of RNA COVID-19 vaccines and risks of spontaneous abortion. New Engl J Med. Sept 8,2021. Doi:https://doi.org/10.1056/NEJMc2113891.
Magnus MC, Gjessing HK, Eide HN, et al, COVID-19 Vaccination during Pregancy and First Trimester Miscarriage. New Engl J Med, 2021;385:2008-2010. Doi: https://doi.org/10.1056/NEJMc2114466.
Ruderman RS, Mormol J, Trawick E, et al. Association of COVID-19 Vacconation During Early Pregnancy with Risk of Congenital Fetal Anomalies. JAMA. Pediatr. April 4, 2022. Doi: https://doi.org/10.1016/j.vaccine.2022.04.031.
V-Safe Pregnancy Registry. COVID-19. Centres for Disease Control and Prevention. Updated July 18,2022. Availabe at: https://www..cdc.gov/coronavirus/2019-ncov/vaccines/safety/vsafepregnancyregistry.html. Accessed Sept 28,2022.
Iliyasu Z, Perkins JM, Tsiga-Ahmed Fl, et al. COVID-19 Vaccine Acceptability Among Pregnant Women in Northern Nigeria. J Obstet Gynaecol Can. 2022;44(4):349-350.
Adeleke R, Alabede O. Geographical determinants and hotspots of out-of-school children in Nigeria. Open Education Studies. 2022; 4(1):345-35.
Elliot TR, Perrin PB, ower MB, Jacobi KS, Warren AM. Predictors of Vaccine Hesistancy among Health Care Workers during the COVID-19 Pandemic. Int. J Environ Res Public Health.2022;19(12):7123.
Marzo RR, Sai W, Alam MZ, Acharya S, Jermsittiporsert K, Songwathana K, et al. Hesitancy in COVID-9 vaccine uptake and its associatted factors among the adult population: a cross sectional study in ix Southeast Asian Countries. Trop Med Health . 2022; 50(4). Available : https://doi.org/10.1186/41182-021-003931. Accessed 3, Nov 2022.
Razzaghi H, Meghani M, Pingali C, et al. COVID-19 Vacciantion Coverage Among Pregnant Women During Pregnancy. Eight Integrated Healthcare Organization, United States. December 14, 2021 - May 8, 2022. MMWR Morb Mortal Wkly Rep. 2021;70(24):895-899.
Malik AA, McFadden SM, Elharake J, Omer SB. Determinats of COVID-19 vaccine acceptance in the US. Eclinical Medicine. 2020;26:100495.
Szilagyi PG, Thomas K, Shah MD, Vizueta N, Cui Y, Vangala S, et al. National trends in the US public's likehood of getting a COVID-19 vaccine - April 1 to December 8, 2020 JAMA. 2021; 325:396-398.
Alemayehu A, Yuuf M, Demissie A, Abdullahi Y. Determinats of COVID-19 vaccine uptake and barrier to being vaccinated among eligibles for COVID-19 vacciantion in Eastern Ethiopia: a community based cross sectional study. SAGE Open Med. (2022). 10:20503121221077585.
Al-Marshoudi S, Al-Balushi H, Al-Wahaibi A, Al-Khalili S, Al-Maani A, Al-Farsi N, et al. Knowledge, Attituide and Practices (KAP) toward the COVID-19 vaccine in Oman: a pre-campaign cross sectional study. Vaccines. (2021)9:602.103390/vaccines9060602.
Reiffersheid L, Marfo E, Assi A, et al. COVID-19 vaccine uptake and intention during pregnancy in Canada. Can J Public Health. 2022;113:547-558.
Cheokol AE, Ayalew TG, Asmare AG, et al. COVID-19 vaccine uptake and assocaieted factors among pregnant women attending antenatal care in Debre Tabor Public Health. 2022; 10.919494. doi:10.3389/fpubh.2022.919494.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Ozori Ebiogbo Stanley, Akanatei Inere Daniel, Olakunle Ifeoluwa Makinde, Adhuze Judith Isioma, Unachukwu Emmanuel Chidozie, Ofuruma Ninabai Napoleon, Osegi Nkencho
This work is licensed under a Creative Commons Attribution 4.0 International License.
